COMBINAISON PHARMACEUTIQUE COMPORTANT UN INHIBITEUR DU RECEPTEUR A ACTIVITE TYROSINE KINASE DE CLASSE III ET LA MOLECULE DE FUSION EDO-S101 INHIBITRICE D'HISTONE DEACETYLASE A EFFET ALKYLANT ET SON UTILISATION DANS LE TRAITEMENT DU CANCER
The present invention is directed to a combination comprising a class III receptor tyrosine kinase inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.